Results 111 to 120 of about 32,506 (196)

Procedural outcomes in patients undergoing non-cardiac surgery with cardiac variant amyloidosis

BMC Anesthesiology
Background Amyloidosis is a complex disease with a multitude of sequalae, particularly with the variants that cause cardiac amyloidosis. There is minimal literature on the types of procedures these patients undergo and the associated postprocedural ...
Michael A. Smith, Maria A. Estevez, Ryan M. Chadha, Emily C. Craver, Melissa A. Lyle, Anna B. Shapiro   +5 more
doaj   +1 more source

Precision medicine with pioneering RNAi therapeutics in ATTR amyloidosis: from bench to bedside

Transthyretin (ATTR) amyloidosis is a multisystem disease caused by misfolding and aggregation of the plasma protein transthyretin (TTR) into insoluble amyloid fibrils in various organs. In clinical practice, ATTRwt amyloidosis manifests as a predominant
Malinverni, Silvia, Porcari, Aldostefano, Verona, Guglielmo, Vergaro, Giuseppe   +3 more
core   +1 more source

Defining Heart Failure Endpoint in ATTR Amyloidosis Clinical Trials: Time for an Update? [PDF]

Cardiol Ther
Gjermeni D, Alexander KM, Januzzi JL, Mahaffey KW.   +3 more
europepmc   +1 more source

Wild type ATTR amyloidosis [PDF]

, 2020
openaire   +1 more source

Wearables for Telemonitoring in ATTR-Amyloidosis: Current Perspectives. [PDF]

Sensors (Basel)
Kind A, Pernice H, Barzen G, Gröschel J, Schumacher A, Werhahn S, Wetzel P, Edelmann F, Hindricks G, Hahn K, Spethmann S.   +10 more
europepmc   +1 more source

Specific therapeutic options for transthyretin amyloidosis

The epidemiology of systemic amyloidosis has recently undergone a spectacular transformation. While light-chain amyloidosis remains a rare disease with a stable incidence, chronic inflammatory disease associated amyloidosis (AA) is diagnosed less ...
Zoltán Pozsonyi
core   +1 more source

Vutrisiran-Mediated Knockdown of Transthyretin in Patients with ATTR Amyloidosis. [PDF]

Clin Pharmacokinet
Fontana M, Algalarrondo V, Garcia-Pavia P, Maurer MS, Gillmore JD, Cappelli F, Kolachana K, Gao X, Jadhav S, Mehrotra N, Robbie G, Badri P.   +11 more
europepmc   +1 more source

Common transthyretin-derived amyloid fibril structures in patients with hereditary ATTR amyloidosis. [PDF]

Nat Commun, 2023
Steinebrei M, Baur J, Pradhan A, Kupfer N, Wiese S, Hegenbart U, Schönland SO, Schmidt M, Fändrich M.   +8 more
europepmc   +1 more source

Utilization and Prognosis of Cardiac Device Implantation in AL Versus ATTR Amyloidosis. [PDF]

Pacing Clin Electrophysiol
Hussain B, Duhan S, Akhtar KH, Seri AR, Akrawinthawong K, Gorthi J, Keisham B, Dasari T.   +7 more
europepmc   +1 more source

ATTR Amyloidosis Concomitant with Parkinsonism and Cardiac Sympathetic Neuropathy. [PDF]

Ann Nucl Cardiol, 2022
Haga F, Oikawa M, Akama J, Kiko T, Yamada S, Yoshihisa A, Nakazato K, Takeishi Y.   +7 more
europepmc   +1 more source